The Cigna Group (WBO:CIGN) Risk Assessment


WBO:CIGN The Cigna Group WBO:CIGN
60 GF Score
Price €252.50
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Cigna Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of The Cigna Group is: High Risk: High uncertainty with risk-return tradeoff.

The Cigna Group  (WBO:CIGN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

The Cigna Group Risk Assessment Related Terms

WBO:CIGN vs ELV, HUM, CNC: Risk Assessment Comparison

For the Healthcare Plans subindustry, The Cigna Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Cigna Group Risk Assessment vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, The Cigna Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where The Cigna Group's Risk Assessment falls into.


WBO:CIGN
60GF Score
The Cigna Group WBO:CIGN
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
60GF Score

Get the complete analysis for WBO:CIGN

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€252.50
Price